The CEO and cofounder of LSVT Global talked about how evidence-based therapies like LSVT LOUD and LSVT BIG can improve speech and movement in patients with Parkinson disease. [WATCH TIME: 5 minutes]
Cynthia Fox, PhD, CCC-SLP
Advertisement
Articles by Cynthia Fox, PhD, CCC-SLP
The CEO and cofounder of LSVT Global highlighted the importance of clinicians referring their patients with Parkinson disease early to evidence-based physical therapies, occupational therapies, and speech therapies. [WATCH TIME: 5 minutes]
Cynthia Fox, PhD, CCC-SLP, CEO and co-founder of LSVT Global, discussed the evolution of rehabilitative therapies in PD and stressed early referrals for speech, physical, and occupational therapy.
Advertisement
Latest Updated Articles
The Growing Care Impact of Speech and Physical Therapy in Parkinson Disease: Cynthia Fox, PhD, CCC-SLPPublished: August 19th 2025 | Updated:
- Optimizing Speech and Movement Therapy to Improve Motor and Nonmotor Symptoms of Parkinson Disease: Cynthia Fox, PhD, CCC-SLP
Published: September 17th 2025 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Eli Lilly’s Anti-Amyloid Therapy Donanemab Gains EU Approval for Alzheimer Disease
2
Ocrelizumab Shows Similar Efficacy to Fingolimod in Phase 3 OPERETTA 2 Trial for Pediatric Relapsing-Remitting MS
3
Phase 3b GAVOTTE Trial Reveals No Added Benefit With Higher-Dose Ocrelizumab in Primary Progressive MS
4
LGMD Awareness Day: A Researcher’s Perspective on Rare Disease Progress and Gaps
5
